FOSUN PHARMA

2196
16.1902.29% ( -0.380 )
Delay Closed: Nov 16, 16:08:11

Financials

Q3 FY2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: FOSUN PHARMA(02196) the Revenue is 11.72 B (+8.58%), Miss estimate;the EBIT is 1.536 B (+22.69%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
11.72B8.58%
12.01B11.26%
-0.29B2.68%
EBITExceed expectations
1.54B22.69%
0.83B33.41%
+0.70B56.10%
EPS
TBA--
0.409520.85%
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 24, 2027
Estimate Revenue49.19 B
Estimate EBIT--
Estimate EPS1.5589

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly